These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6345575)

  • 1. Killer system: a simple method for differentiating Candida albicans strains.
    Polonelli L; Archibusacci C; Sestito M; Morace G
    J Clin Microbiol; 1983 May; 17(5):774-80. PubMed ID: 6345575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain differentiation of pathogenic yeasts by the killer system.
    Morace G; Archibusacci C; Sestito M; Polonelli L
    Mycopathologia; 1984 Feb; 84(2-3):81-5. PubMed ID: 6371541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Candida infection. I. Use of killer system for typing of Candida albicans strains.
    Budak A
    Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):359-67. PubMed ID: 2130801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between killer yeasts and pathogenic fungi.
    Walker GM; McLeod AH; Hodgson VJ
    FEMS Microbiol Lett; 1995 Apr; 127(3):213-22. PubMed ID: 7758935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination between Candida albicans and other pathogenic species of the genus Candida by their differential sensitivities to toxins of a panel of killer yeasts.
    Buzzini P; Martini A
    J Clin Microbiol; 2001 Sep; 39(9):3362-4. PubMed ID: 11526179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of killer toxins for computer-aided differentiation of Candida albicans strains.
    Polonelli L; Castagnola M; Rossetti DV; Morace G
    Mycopathologia; 1985 Sep; 91(3):175-9. PubMed ID: 3903510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The differentiation of Candida albicans strains by the killer system].
    Candido RC; Fischman O; Zaror L; Ito IY
    Rev Soc Bras Med Trop; 1995; 28(4):321-4. PubMed ID: 8668830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluation of the yeast killer phenomenon.
    Polonelli L; Morace G
    J Clin Microbiol; 1986 Nov; 24(5):866-9. PubMed ID: 3771773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Candida infection. III. A proposal for a new typing system for Candida albicans strains.
    Budak A
    Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):379-85. PubMed ID: 2130803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killer phenomenon in pathogenic yeast.
    Kandel JS; Stern TA
    Antimicrob Agents Chemother; 1979 Apr; 15(4):568-71. PubMed ID: 572656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of sensitivity to yeast killer toxins among Candida and Torulopsis isolates of human origin.
    Middelbeek EJ; Hermans JM; Stumm C; Muytjens HL
    Antimicrob Agents Chemother; 1980 Mar; 17(3):350-4. PubMed ID: 7191690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale screening of selected Candida maltosa, Debaryomyces hansenii and Pichia anomala killer toxin activity against pathogenic yeasts.
    Buzzini P; Martini A
    Med Mycol; 2001 Dec; 39(6):479-82. PubMed ID: 11798052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses].
    Sangorrín MP; Lopes CA; Rivero A; Caballero AC
    Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the killer toxin of several yeasts and the purification of a toxin of type K2.
    Pfeiffer P; Radler F
    Arch Microbiol; 1984 Apr; 137(4):357-61. PubMed ID: 6375620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of killer yeasts in isolates of clinical origin.
    Robledo-Leal E; Villarreal-Treviño L; González GM
    Trop Biomed; 2012 Jun; 29(2):297-300. PubMed ID: 22735852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Killer activity of yeasts isolated from the water environment.
    Vadkertiová R; Sláviková E
    Can J Microbiol; 1995 Sep; 41(9):759-66. PubMed ID: 7585352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer activity of yeasts isolated from natural environments against some medically important Candida species.
    Vadkertiová R; Sláviková E
    Pol J Microbiol; 2007; 56(1):39-43. PubMed ID: 17419188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaerobic yeast killer systems.
    Polonelli L; Menozzi MG; Campani L; Gerloni M; Conti S; Morace G; Chezzi C
    Eur J Epidemiol; 1992 May; 8(3):471-6. PubMed ID: 1397211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killer toxins of certain yeast strains have potential growth inhibitory activity on gram-positive pathogenic bacteria.
    Izgü F; Altinbay D
    Microbios; 1997; 89(358):15-22. PubMed ID: 9218351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.